Evidence map›Paper›PMID 23193189›Full record

Trial reportDiabetes2013

Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study.

Christian Høst, Lars C Gormsen, Britt Christensen, Niels Jessen, David M Hougaard, Jens S Christiansen, Steen B Pedersen, Michael D Jensen, Søren Nielsen, Claus H Gravholt

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Acute Testosterone Deficiency Alters Adipose Tissue Fatty Acid Storage.The Journal of clinical endocrinology and metabolism · 2017
    Trial
  3. Trial
  4. Article
  5. Very low-density lipoprotein and the human health.World journal of experimental medicine · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The Metabolic Syndrome, a Human Disease.International journal of molecular sciences · 2024
    Review
  11. Review
  12. The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2022
    Review
  13. Review
  14. Metabolic flexibility during sleep.Scientific reports · 2021
    Article
  15. LPCN 1144 Resolves NAFLD in Hypogonadal Males.Hepatology communications · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Christian HøstDepartment of Endocrinology and Internal Medicine and the Medical Research Laboratories, Clinical Institute, Aarhus University Hospital, Aarhus, Denmark. christian.host@ki.au.dk
Lars C Gormsen
Britt Christensen
Niels Jessen
David M Hougaard
Jens S Christiansen
Steen B Pedersen
Michael D Jensen
Søren Nielsen
Claus H Gravholt
Aarhus University Hospital · DKMayo Clinic · USStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low testosterone (T) levels in men have been shown to predict development of the metabolic syndrome, but the effects of T on lipid metabolism are incompletely understood. In a randomized, double-blind, placebo-controlled, crossover study, 12 healthy, young males received gonadotropin-releasing hormone agonist treatment 1 month prior to 3 of 4 trial days to induce castrate levels of T. On trial days, T gel was applied to the body containing either high or low physiological T dose or placebo. On the 4th trial day, participants constituted their own eugonadal controls. Each study comprised a 5-h basal period and a 3-h hyperinsulinemic-euglycemic clamp. Short-term hypogonadism did not affect VLDL triglyceride (TG) secretion, nor did it affect VLDL-TG concentrations. It was, however, characterized by lower total lipid oxidation. In addition, acute rescue with high physiological T increased VLDL-TG secretion during both basal and clamp conditions. These data show that T can act through fast nongenomic pathways in the liver. In addition, the early hypogonadal state is characterized by decreased total lipid oxidation, but whether these changes represent early hypogonadal metabolic dysfunction warrants further investigations. T is not a major determinant of resting VLDL-TG kinetics in men.

Indexed as

LipolysisAdministration, CutaneousAdultAndrogensCarbon RadioisotopesCross-Over StudiesDelayed-Action PreparationsDose-Response Relationship, DrugDouble-Blind MethodGonadotropin-Releasing HormoneHormone Replacement TherapyHumansHypogonadismKineticsLeuprolideLipoproteins, VLDLAndrogensCarbon RadioisotopesDelayed-Action PreparationsGonadotropin-Releasing HormoneLeuprolideLipoproteins, VLDLluprolide acetate gel depotTestosteroneTriglyceridesTriolein

Identifiers

PMID23193189
PMCPMC3636625
OpenAlexW2117868069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.